D-1115-2015 Class III Terminated
FDA drug recall D-1115-2015 was initiated by Sandoz, Inc on Apr 15, 2015 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: An out of specification (OOS) result was reported for impurity at the 21 month stability time point. The recall status is terminated (terminated Oct 5, 2016). Affected quantity: 1,023,430 units.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 10, 2015
- Initiation Date
- Apr 15, 2015
- Termination Date
- Oct 5, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,023,430 units
Product description
Cetirizine HCl Chewable Tablet, 10 mg, 6-tablets in one blister, in 12 (2 blisters) and 24 (4 blisters) tablet count configurations. Manufactured by Sandoz Private Limited Village-Digham Opp. Thane-Belapur Road Navi Mumbai, 400 078, India, for Sandoz Private Limited 100 College Road West, Princeton, NJ 08540. NDC 66394-041-06
Reason for recall
Failed Impurities/Degradation Specifications: An out of specification (OOS) result was reported for impurity at the 21 month stability time point.
Distribution pattern
Nationwide
Code information
Lot #: DP3841, DP5237, DP5238, DP5238A, DP5238B Exp 05/2015; DR7807, DR9954, DR9959, DV5838, Exp 07/2015.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1115-2015
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026